Hemogenyx Pharma PLC - biopharmaceutical company focused on treatments for blood diseases - announces that the second patient has been successfully treated as part of the ongoing Phase I clinical ...

Our task now is to carry this momentum forward into the coming year and beyond, converting our exploration success into tangible value for our shareholders." Digital 9 Infrastructure PLC - ...

(Sharecast News) - London stocks ended the week on a positive note on Friday, buoyed by upbeat global developments and solid US employment data. The FTSE 100 index advanced 1.17% to close at 8,596.35 ...

"Private sector payrolls were also stronger than expected, and at roughly the same rate as the downwardly revised figure for March, while the unemployment rate remained steady at 4.2%. The 3-month ...

(Alliance News) - The trade secretary has said that businesses will "continue to be at the heart" of the UK government's decisions in response to Donald Trump's trade tariffs, as a four-week ...

(Alliance News) - Third Point Investors Ltd on Friday said its flagship Offshore Fund declined 3.7% in the first quarter as "US tariff announcements and the prospect of a global trade war weighed on ...

Stocks are moving higher after Beijing opened the door to trade talks with Washington and Brussels offered to increase its purchases of US goods. The above ahead of a reading on the US non-farm ...

(Alliance News) - RTW Biotech Opportunities Ltd on Friday noted positive trial data from investee Artios Pharma, for the ongoing study of its lead candidate ART0380. RTW Biotech is a Guernsey, England ...

We rely on ads to keep creating quality content for you to enjoy for free. Participate in Share Chat. Set up virtual watchlists and portfolios See more trades and share info.

(Correcting that Amigo Holdings PLC made a narrowed loss of GBP200,000 against the prior year's GBP12.7 million loss, as opposed to swinging to loss from profit.) (Alliance News) - The following ...

While London South East do their best to maintain the high quality of the information displayed on this site, we cannot ...

(Alliance News) - Nuformix PLC on Friday said it has continued to "advance and exploit" assets in its portfolio, two days after noting a positive opinion from an EU committee for NXP002.